# Two new 16-week tuberculosis regimens advance in clinical trial

Source: [Medical Xpress - latest medical and health news stories](https://medicalxpress.com/news/2026-11-week-tuberculosis-regimens-advance-clinical.html) · 2026-11-19 · Medicine
Page: https://themorning.science/story/two-new-16-week-tuberculosis-regimens-advance-in-clinical-trial-87acbce1b1e0428b
Kind: research · Impact: medium

## In brief

- Two new 16-week tuberculosis treatment regimens have advanced in a clinical trial.
- Tuberculosis causes more than 1 million deaths each year, according to the source.
- Current TB treatment is described as lengthy and burdened by side effects.

## Why it matters

Shorter TB regimens could reduce treatment duration and side-effect burden for patients, which matters for global infectious disease control.

## Timeline

- 2026-11-19: Medical Xpress reports that two new 16-week tuberculosis regimens advance in clinical trial

## Coverage

- [Two new 16-week tuberculosis regimens advance in clinical trial](https://medicalxpress.com/news/2026-11-week-tuberculosis-regimens-advance-clinical.html) — Medical Xpress - latest medical and health news stories, 2026-11-19

Tags: tuberculosis, clinical trial, infectious disease, drug development, treatment regimen

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science
